Adaptive Biotechnologies Corporation (ADPT)
Healthcare • Diagnostics & Research
StockNasdaqGSUnited StatesUS00650F1093
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Adaptive Biotechnologies Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:26. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 04 Feb 2027 16:00 | -0.04 | — | — | Upcoming |
| 04 Nov 2026 16:00 | -0.10 | 0.02 | +120.3% | Beat |
| 29 Jul 2026 16:00 | -0.13 | -0.25 | -86.0% | Miss |
| 05 May 2026 16:00 | -0.16 | -0.13 | +20.2% | Beat |
| 05 Feb 2026 16:00 | -0.18 | -0.09 | +50.8% | Beat |
| 05 Nov 2025 16:00 | -0.14 | 0.06 | +143.3% | Beat |
| 05 Aug 2025 16:00 | -0.24 | -0.17 | +28.6% | Beat |
| 01 May 2025 16:00 | -0.31 | -0.20 | +35.5% | Beat |
| 11 Feb 2025 16:00 | -0.24 | -0.23 | +5.2% | Beat |
| 07 Nov 2024 16:00 | -0.27 | -0.22 | +19.8% | Beat |
| 01 Aug 2024 16:00 | -0.33 | -0.29 | +12.0% | Beat |
| 07 May 2024 16:00 | -0.34 | -0.32 | +6.2% | Beat |
| 14 Feb 2024 16:00 | -0.33 | -0.30 | +7.0% | Beat |
| 09 Nov 2023 16:00 | -0.34 | -0.35 | -4.5% | Miss |
| 02 Aug 2023 16:00 | -0.35 | -0.33 | +4.5% | Beat |
| 03 May 2023 16:00 | -0.37 | -0.40 | -9.2% | Miss |
| 14 Feb 2023 16:00 | -0.35 | -0.28 | +19.7% | Beat |
| 03 Nov 2022 16:00 | -0.38 | -0.32 | +14.7% | Beat |
| 03 Aug 2022 16:00 | -0.43 | -0.37 | +13.7% | Beat |
| 04 May 2022 16:00 | -0.45 | -0.44 | +2.5% | Beat |
| 15 Feb 2022 16:00 | -0.45 | -0.43 | +4.8% | Beat |
| 03 Nov 2021 16:00 | -0.43 | -0.40 | +6.2% | Beat |
| 04 Aug 2021 16:00 | -0.41 | -0.35 | +14.9% | Beat |
| 05 May 2021 16:00 | -0.40 | -0.29 | +27.8% | Beat |
| 24 Feb 2021 16:00 | -0.29 | -0.33 | -12.3% | Miss |
| 10 Nov 2020 16:00 | -0.28 | -0.27 | +4.1% | Beat |
| 10 Aug 2020 16:00 | -0.28 | -0.26 | +7.6% | Beat |
| 12 May 2020 16:00 | -0.21 | -0.25 | -17.9% | Miss |
| 26 Feb 2020 16:00 | -0.14 | -0.17 | -21.4% | Miss |
| 12 Nov 2019 16:00 | -0.22 | -0.11 | +50.6% | Beat |
| 13 Aug 2019 16:00 | -0.14 | -0.13 | +5.7% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 277M | +54.8% | -59.5M | -21.5% | -0.39 | +63.9% | -48.9M |
| 2024 | 179M | +5.1% | -159.5M | -89.1% | -1.08 | +30.8% | -98.9M |
| 2023 | 170.3M | -8.1% | -225.3M | -132.3% | -1.56 | -11.4% | -167M |
| 2022 | 185.3M | — | -200.2M | -108.0% | -1.40 | — | -200.3M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 26.98 | 32.21 | 24.80 | 28.71 | +7.77% | 23,518,921 | |
| Oct 2026 | 28.89 | 30.74 | 23.82 | 26.64 | -7.82% | 47,687,100 | |
| Sep 2026 | 24.91 | 29.96 | 23.53 | 28.90 | +15.97% | 47,216,800 | |
| Aug 2026 | 22.92 | 26.87 | 21.83 | 24.92 | +10.41% | 44,038,200 | |
| Jul 2026 | 21.46 | 24.57 | 19.77 | 22.57 | +5.22% | 61,593,800 | |
| Jun 2026 | 14.99 | 21.64 | 14.74 | 21.45 | +41.58% | 81,961,500 | |
| May 2026 | 14.20 | 15.59 | 12.50 | 15.15 | +7.45% | 36,568,600 | |
| Apr 2026 | 14.00 | 15.61 | 12.36 | 14.10 | +1.59% | 33,117,700 | |
| Mar 2026 | 15.51 | 16.95 | 12.00 | 13.88 | -13.36% | 51,450,600 | |
| Feb 2026 | 18.29 | 19.80 | 14.76 | 16.02 | -13.41% | 35,275,000 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- DNA Sequencing - Global Strategic Business Report: Secure Share of a US$17.1 Billion Market by 2030 as Eppendorf, Adaptive Biotechnologies, BGI Genomics, and Annoroad Reshape Competition (opens in a new tab) 11 Nov 2026 14:23
- Adaptive Biotechnologies to Participate in Upcoming Investor Conferences (opens in a new tab) 10 Nov 2026 21:05
- Are Medical Stocks Lagging Halozyme Therapeutics (HALO) This Year? (opens in a new tab) Zacks · 10 Nov 2026 13:40
- Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run? (opens in a new tab) Zacks · 10 Nov 2026 13:15
- Guggenheim Maintains Buy on Adaptive Biotechnologies, Raises Price Target to $34 (opens in a new tab) Benzinga · 10 Nov 2026 09:50
- Adaptive Biotechnologies Corporation 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 09 Nov 2026 18:17
- Adaptive Biotechnologies (ADPT) Reported Mixed Q3 Results, Is The Stock Fully Valued? (opens in a new tab) Simply Wall St. · 08 Nov 2026 00:19
- Adaptive (ADPT) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 15:13
- Adaptive Biotechnologies Corp (ADPT) Q3 2026 Earnings Call Highlights: First Profitable Quarter ... (opens in a new tab) GuruFocus.com · 05 Nov 2026 07:14
- Adaptive Biotechnologies Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 05 Nov 2026 00:14
- Adaptive Biotechnologies (ADPT) Q3 Earnings and Revenues Top Estimates (opens in a new tab) Zacks · 04 Nov 2026 23:45
- Adaptive Biotechnologies (ADPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (opens in a new tab) Zacks · 04 Nov 2026 23:00
- Adaptive Biotechnologies: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 04 Nov 2026 21:55
- Adaptive Biotechnologies Corporation (ADPT) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 04 Nov 2026 21:24
- Adaptive Biotechnologies Reports Third Quarter 2026 Financial Results (opens in a new tab) 04 Nov 2026 21:05
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 29.48 USD
- Market cap
- 4.8B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow ADPT and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.